TY - JOUR
T1 - Talking About Death With Terminally-Ill Cancer Patients
T2 - What Contributes to the Regret of Bereaved Family Members?
AU - Mori, Masanori
AU - Yoshida, Saran
AU - Shiozaki, Mariko
AU - Baba, Mika
AU - Morita, Tatsuya
AU - Aoyama, Maho
AU - Kizawa, Yoshiyuki
AU - Tsuneto, Satoru
AU - Shima, Yasuo
AU - Miyashita, Mitsunori
N1 - Funding Information:
This study was conducted with the cooperation of Hospice Palliative Care Japan (HPCJ). The authors would like to thank all participants and participating institutions for taking part in this study. This study was part of The Japan Hospice and Palliative Care Evaluation Study, funded by Japan Hospice Palliative Care Foundation, and in part supported by Japan Society for the Promotion of Science KAKENHI Grant Number JP16K15418.
Publisher Copyright:
© 2017 American Academy of Hospice and Palliative Medicine
PY - 2017/12
Y1 - 2017/12
N2 - Context Talking about death is an important issue for terminally-ill cancer patients and their families. Little is known about how often and which bereaved families regret not having talked about death with their deceased loved one. Objectives To explore the prevalence of a regret of not having talked about death with a deceased loved one among bereaved family members of adult cancer patients, and to systematically explore factors contributing to their regret. Methods We conducted a nationwide survey of 999 bereaved families of cancer patients admitted to 133 inpatient hospices in Japan and surveyed families' regret on talking about death. Exploratory analyses identified the underlying structures of process, option, and outcome subscales of factors contributing to regret. Results Among 678 bereaved families (response rate 68%), 224 (33%) regretted not having talked about death sufficiently, whereas 40 (5.9%) conversely regretted having talked about death. Three process factors (“prognostic disclosure to patient” [β = 0.082, P = 0.039], “upsetting of patient and family” [β = 0.127, P = 0.001], and “family's sense of uncertainty about when to act based on terminal awareness” [β = 0.141, P = 0.000]) and an outcome factor (“having achieved a good death” [β = −0.152, P = 0.000]) contributed to the regret of talking insufficiently. Conclusion A third of bereaved families of adult cancer patients regretted not having talked about death sufficiently. Clinicians may minimize this regret by facilitating a shared understanding of the disease and prognosis, advising families explicitly when to talk based on terminal awareness, providing continuous emotional support, and validating their decision on talking about death.
AB - Context Talking about death is an important issue for terminally-ill cancer patients and their families. Little is known about how often and which bereaved families regret not having talked about death with their deceased loved one. Objectives To explore the prevalence of a regret of not having talked about death with a deceased loved one among bereaved family members of adult cancer patients, and to systematically explore factors contributing to their regret. Methods We conducted a nationwide survey of 999 bereaved families of cancer patients admitted to 133 inpatient hospices in Japan and surveyed families' regret on talking about death. Exploratory analyses identified the underlying structures of process, option, and outcome subscales of factors contributing to regret. Results Among 678 bereaved families (response rate 68%), 224 (33%) regretted not having talked about death sufficiently, whereas 40 (5.9%) conversely regretted having talked about death. Three process factors (“prognostic disclosure to patient” [β = 0.082, P = 0.039], “upsetting of patient and family” [β = 0.127, P = 0.001], and “family's sense of uncertainty about when to act based on terminal awareness” [β = 0.141, P = 0.000]) and an outcome factor (“having achieved a good death” [β = −0.152, P = 0.000]) contributed to the regret of talking insufficiently. Conclusion A third of bereaved families of adult cancer patients regretted not having talked about death sufficiently. Clinicians may minimize this regret by facilitating a shared understanding of the disease and prognosis, advising families explicitly when to talk based on terminal awareness, providing continuous emotional support, and validating their decision on talking about death.
KW - End-of-life discussion
KW - bereaved family
KW - cancer
KW - regret
UR - http://www.scopus.com/inward/record.url?scp=85030684063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030684063&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2017.02.021
DO - 10.1016/j.jpainsymman.2017.02.021
M3 - Article
C2 - 28797852
AN - SCOPUS:85030684063
SN - 0885-3924
VL - 54
SP - 853-860.e1
JO - Journal of Pain and Symptom Management
JF - Journal of Pain and Symptom Management
IS - 6
ER -